Drug Profile
CIGB 845
Alternative Names: CIGB845Latest Information Update: 28 Mar 2018
Price :
$50
*
At a glance
- Originator Center for Genetic Engineering and Biotechnology
- Class Peptides; Recombinant proteins
- Mechanism of Action Growth hormone releasing factor agonists; Myelin protein stimulants; Neurogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 28 Mar 2018 No recent reports of development identified for preclinical development in Neurological-disorders in Cuba (Parenteral)
- 30 Aug 2016 The Centre for Genetic Engineering and Biotechnology plans to initiate phase I trial in Cerebral infarction in Cuba (RPCEC00000214)
- 01 Jan 2013 Preclinical trials in Neurological disorders in Cuba (Parenteral)